NCT05326360View on ClinicalTrials.gov

Ramosetron on Late PONV (Postoperative Nausea and Vomiting)

PHASE4CompletedINTERVENTIONAL

Enrollment

144

Participants

Timeline

Start Date

December 17, 2020

Primary Completion Date

October 31, 2021

Study Completion Date

October 31, 2021

Conditions

Postoperative Nausea and VomitingBreast Cancer Female

Interventions

DRUG

Ramosetron Hydrochloride

we injected two additional remosetron doses in different way in experimental groups. In group B, patients received additional ramosetron at 12 hour interval, in group M, patients received additional ramosetron in mixed with the patient controlled analgesia regimen.

Trial Locations (1)

49241

Pusan National University Hopsital, Busan

All Listed Sponsors

lead

Pusan National University Hospital

OTHER

NCT05326360 - Ramosetron on Late PONV (Postoperative Nausea and Vomiting) | Biotech Hunter | Biotech Hunter